Cover Image

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies

No population-based cohort study investigated a potential inverse association between long-term low-dose acetylsalicylic acid (ASA) use and all-cause dementia and its two most common sub-types Alzheimer’s disease (AD) and vascular dementia (VD) so far.

Saved in:
Bibliographic Details
Main Authors: Nguyen, Thi Ngoc Mai (Author) , Chen, Li-Ju (Author) , Trares, Kira (Author) , Stocker, Hannah (Author) , Holleczek, Bernd (Author) , Beyreuther, Konrad (Author) , Brenner, Hermann (Author) , Schöttker, Ben (Author)
Format: Article (Journal)
Language:English
Published: 28 May 2022
In: Alzheimer's research & therapy
Year: 2022, Volume: 14, Pages: 1-14
ISSN:1758-9193
DOI:10.1186/s13195-022-01017-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13195-022-01017-4
Get full text
Author Notes:Thi Ngoc Mai Nguyen, Li-Ju Chen, Kira Trares, Hannah Stocker, Bernd Holleczek, Konrad Beyreuther, Hermann Brenner and Ben Schöttker
Description
Summary:No population-based cohort study investigated a potential inverse association between long-term low-dose acetylsalicylic acid (ASA) use and all-cause dementia and its two most common sub-types Alzheimer’s disease (AD) and vascular dementia (VD) so far.
Item Description:Gesehen am 07.07.2022
Physical Description:Online Resource
ISSN:1758-9193
DOI:10.1186/s13195-022-01017-4

Similar Items